Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases

Prostate

Volumn 36, Issue 1, 1998, Pages 1-7

  Di Silverio, Franco ^a   Sciarra, Alessandro ^a   D'Eramo, Giuseppe ^a   Casale, Paolo ^a   Loreto, Andrea ^a   Seccareccia, Fulvia ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Aging; Benign prostatic hyperplasia; Prostate carcinoma; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; QUESTIONNAIRE; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; UROLOGIC DISEASES;

EID: 0032526568     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980615)36:1<1::AID-PROS1>3.0.CO;2-M     Document Type: Article

References (26)

1. Wang MC, Valenzuela LA, Murphy CP, Chu TM: Purification of a human prostate-specific antigen. Invest Urol 1979;17:159-163.
2. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-916.
3. Roehrborn CG, Andersen JT, Correa R, Di Silverio F, Kaplan SA, Kurth KH, Rubben H, Torp-Pedersen ST, Watanabe H, Zerbib M: Initial diagnostic evaluation of men with lower urinary tract symptoms. In Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy C (eds): "The Third International Consultation on Benign Prostatic Hyperplasia." Monaco: 1995: 169-219.
4. Bazinet M, Meshref AW, Trudel C, Aronson S, Peloquin F, Nachabe M, Begin LR, Elhilali MM: Prospective evaluation of prostate specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology 1994;43:44-51.
5. Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Pohl CE, Sieber PR, Stahl CA: The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol 1994;151:88-93.
6. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM: Serum prostate specific antigen in a community based population of healthy men. JAMA 1993;270: 860-864.
7. Sciarra A, D'Eramo G, Casale P, Loreto A, Buscarini M, Di Nicola S, Seccareccia F, Di Silverio F: Relationship among symptom score,prostate volume and urinary flow rates in 543 patients with and without benign prostatic hyperplasia. Prostate 1998;34:121-128.
8. Cockett AT, Aso Y, Denis L, Murphy G, Khoury S, and Members of the Committees: Recommendations of the International Consensus Committee. In Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds): "The Third International Consultation on Benign Prostatic Hyperplasia." Monaco: 1995:625-640.
9. Terris MK, Stamey TA: Determination of prostate volume by transrectal ultrasound. J Urol 1991;145:984-987.
10. Elveback LR, Guillier CL, Keating FR Jr: Health, normality and the ghost of Gauss. JAMA 1970;211:69-75.
11. Lepor H, Machi G: Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 1993;42:36-41.
12. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992;147:817-821.
13. Babaian RJ, Fritsche HA, Evans RB: PSA and prostate gland volume: Correlation and clinical application. J Clin Lab 1990;4: 135-137.
14. Dalkin BL, Ahmann F, Southwick P, Bottaccini MR: Derivation of normal prostate specific antigen (PSA) level by age [abstract]. J Urol 1993;149:413.
15. Dalkin BL, Ahmann FR, Kopp JP: Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma. J Urol 1993;150:1837-1839.
16. Collins GN, Lee RJ, McKelvie GB, Rogers AC, Hehir M: Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 1993;71:445-450.
17. Oesterling JE, Jacobsen SJ, Cooner WH: The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older. J Urol 1995;153:1160-1163.
18. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, Edmond J: Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 1992;147:846-852.
19. Lee F, Littrup PJ, Loft-Christensen L, Kelly BS, McHugh TA, Siders DB, Mitchell AE, Newby JE: Predicted prostate specific antigen results using transrectal ultrasound gland volume. Cancer 1992;70:211-220.
20. Kirollos MM: Prostate specific antigen and age. Is there a correlation? And why does it seem to vary? Eur Urol 1996;30:296-301.
21. Weber JP, Oesterling JE, Peters CA, Partin AW, Chan DW, Walsh PC: The influence of reversible androgen deprivation on serum prostate specific antigen levels in men with benign prostatic hyperplasia. J Urol 1989;141:987-992.
22. Barry MJ, Boyle P, Fourcroy J, Garraway M, Gu FL, Harrison NW, Jacobsen SJ, O'Leary MP, Oishi T, Tsukamoto T, Guess HA: Epidemiology and natural history of BPH. In Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds): "The Third International Consultation on Benign Prostatic Hyperplasia." Monaco: 1995:21-36.
23. Carter HB, Pearson JD, Metter EJ: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992;267:2215-2220.
24. Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. Radical prostatectomy treated patients. J Urol 1989;141:1076-1084.
25. Kyprianou N, Martikainen P, Isaacs JT: Programmed cell death of normal and malignant prostatic cells. In Voigt KD, Knabbe C (eds): "Endocrine Dependent Tumors." New York: Raven Press, 1991:69-81.
26. Oesterling JE, Bilhartz DL, Tindall DJ: Clinically useful serum markers for adenocarcinoma of the prostate, II: Prostate specific antigen. Am Urol Assoc Update Ser 1991;10:137-144.